| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34909-10ug | |||
| Carrier-Free | NBP2-34909-1mg | |||
| Carrier-Free | NBP2-34909-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12021-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81082-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35280-10ug | |||
| Carrier-Free | NBP2-35280-1mg | |||
| Carrier-Free | NBP2-35280-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35102-10ug | |||
| Carrier-Free | NBP2-35102-1mg | |||
| Carrier-Free | NBP2-35102-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34897-10ug | |||
| Carrier-Free | NBP2-34897-1mg | |||
| Carrier-Free | NBP2-34897-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35171-1mg | |||
| Carrier-Free | NBP2-35171-100ug | |||
| Carrier-Free | NBP2-35171-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81120-0.025mg | |||
![SDS-Page: Human IL-9 Protein [NBP2-34909]](http://images.novusbio.com/fullsize/Human-IL-9-Protein-SDS-Page-NBP2-34909-img0001.jpg "SDS-Page: Human IL-9 Protein [NBP2-34909]")
![Flow Cytometry: IL-9 Antibody (D9302C12) - Chimeric [NBP3-12021] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of D9302C12 (NBP3-12021, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-9-Antibody-D9302C12-Chimeric-Flow-Cytometry-NBP3-12021-img0001.jpg "Flow Cytometry: IL-9 Antibody (D9302C12) - Chimeric [NBP3-12021] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of D9302C12 (NBP3-12021, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![Flow Cytometry: TGF-alpha Antibody (tAb2) [NBP2-81082] - Flow-cytometry using the [NBP2-81082]. Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of tAb2 (NBP2-81082, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/TGF-alpha-Antibody-tAb2-Flow-Cytometry-NBP2-81082-img0001.jpg "Flow Cytometry: TGF-alpha Antibody (tAb2) [NBP2-81082] - Flow-cytometry using the [NBP2-81082]. Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of tAb2 (NBP2-81082, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Recombinant Rat Oncostatin M/OSM Protein [NBP2-35280]](http://images.novusbio.com/fullsize/Recombinant-Rat-Oncostatin-M-OSM-Protein-SDS-Page-NBP2-35280-img0002.jpg "SDS-Page: Recombinant Rat Oncostatin M/OSM Protein [NBP2-35280]")
![Western Blot: AIF [p Ser116] Antibody [NBP3-23346] - Western blot image of human jurkat cells untreated (lanes 1 & 3) or treated with calyculin A (100 nM, 30 min.) (lanes 2 and 4). The blot was probed with rabbit polyclonals anti-AIF (C-terminal region) at 1:500 (lanes 1 & 2) and anti-AIF (Ser-116) phospho-specific antibody at 1:1000 (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23346_rabbit-aif-p-ser116-pab-1992023191546.jpg "Western Blot: AIF [p Ser116] Antibody [NBP3-23346] - Western blot image of human jurkat cells untreated (lanes 1 & 3) or treated with calyculin A (100 nM, 30 min.) (lanes 2 and 4). The blot was probed with rabbit polyclonals anti-AIF (C-terminal region) at 1:500 (lanes 1 & 2) and anti-AIF (Ser-116) phospho-specific antibody at 1:1000 (lanes 3 & 4).")
![SDS-Page: Recombinant Human IGF-I/IGF-1 LR3 Protein [NBP2-61314]](http://images.novusbio.com/fullsize/nbp2-61314_recombinant-human-igf-i-igf-1-lr3-protein-512024857291.png "SDS-Page: Recombinant Human IGF-I/IGF-1 LR3 Protein [NBP2-61314]")
![SDS-Page: Mouse IL-11 Protein [NBP2-35102]](http://images.novusbio.com/fullsize/Mouse-IL-11-Protein-SDS-Page-NBP2-35102-img0001.jpg "SDS-Page: Mouse IL-11 Protein [NBP2-35102]")
![SDS-Page: Human IL-5 Protein [NBP2-34897]](http://images.novusbio.com/fullsize/Human-IL-5-Protein-SDS-Page-NBP2-34897-img0002.jpg "SDS-Page: Human IL-5 Protein [NBP2-34897]")
![SDS-Page: Mouse Midkine Protein [NBP2-35171]](http://images.novusbio.com/fullsize/Mouse-Midkine-Protein-SDS-Page-NBP2-35171-img0001.jpg "SDS-Page: Mouse Midkine Protein [NBP2-35171]")